Скачать

Biological Defence Research, Land Division, Defence Science and Technology Group

2. Где он находится (указать адрес и географическое местонахождение)?
Chemical, and Biological, Radiological and Nuclear Defence LAND DIVISION 506 Lorimer Street Fishermans Bend VIC 3207 AUSTRALIA

506 Lorimer Street

Fishermans Bend  VIC  3207

AUSTRALIA

3. Площадь лабораторных помещений с разбивкой по уровню изоляции
BL 3 , 60.00 м2
BL 2 , 150.00 м2
Общая площадь лабораторных помещений (м(2))
210

4. Организационная структура каждого объекта

(viii) Кратко охарактеризовать политику объекта в отношении публикаций

Publication in scientific journals is encouraged, as it is a mechanism for staff to maintain their professional status.

(ix) Представить перечень общедоступных документов и докладов, явившихся результатом проделанной работы, которые были опубликованы за предыдущие 12 месяцев. (Указать авторов, названия и полные выходные данные.)

Land Division, Defence Science and Technology (DST) Group

The policy of the Defence Science and Technology Group is to publish results of general scientific value in open literature. Information that is more specialised and relevant particularly to defence is published in laboratory reports, which are unclassified and available to the public, unless they contain information that might prejudice the security of Australia or information that is “commercial-in-confidence”. Most results of the biological research will be either unclassified or “commercial-in-confidence”.

Journal Papers

Nil in 2021

Conference papers/proceedings or book chapters

Nil in 2021

Заметки
Н/Д
Вложения
Н/Д
5. Кратко охарактеризовать деятельность в области биологической защиты, осуществляемую на объекте, включая вид(ы) изучаемых микроорганизмов1 и/или токсинов, а также наружные исследования биологических аэрозолей.

Various types of work are undertaken, as outlined in the following sections:

 

(1) Detection of biological entities recognised as potential biological warfare agents

Immunological, bacteriophage, mass spectrometry and DNA-based techniques for rapid identification of BWA (Biological Warfare Agents) are being developed/assessed.

Current research focuses on the evaluation of platforms and reagents that enable rapid identification and characterisation of bacterial, viral and toxin agents, including microbial antibiotic resistance and genetically manipulated bacteria.

(2) Development of health monitoring systems for BWA

A virology program aims to provide environmental and ADF personnel immunological screening for known or poorly characterised endemic viruses, particular to Australia and the region such as Ross River Virus, Murray Valley Encephalitis Virus, bunya–viruses, rhabdo–viruses, Japanese encephalitis, dengue and filoviruses.

(3) Physical methods for rapid detection of bio-aerosols

Methods of particle characterisation for provision of rapid warning of a bio-aerosol are being assessed.

(4) Protection/Treatment/Toxicology

Neutralization and cytotoxicity assays have been developed to assess the usefulness of potential therapeutic agents such as antibodies and antimicrobial peptides.

Human and mouse lung cells have been used as a test bed for examining potential therapeutic compounds against toxin agents. Compounds for treatment of ricin intoxication are currently being examined.

A program of work developing Good Laboratory Practice (GLP) manufacturing processes for medical counter-measures has been completed with Monash University and Defence Research and Development Canada (DRDC).  National Association of Testing Authorities (NATA) accreditation of this facility was granted in 2019.

(5) Detection of biological toxins using physico-chemical methods

Studies on detection of biological material using mass spectrometry and other physico-chemical methods are being conducted to determine their utility for field detection of biological toxins and BWC verification procedures.  This work has included the analysis of ricin and crude extracts of ricin by matrix-assisted laser desorption/ionization (MALDI) and fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry.

(6) Hollow-Fibre Infection model (HFIM) evaluation of therapeutics

DSTG is evaluating the use of the HFIM to predict bacterial responses to current, repurposed or novel therapeutics.  The outcomes of this treatment (which will occur over a period of time) will act as a preliminary screening method to be used before clinical or animal trials.

(7) Strengthening the Biological Weapons Convention (BWC)

A number of BWC/Biosecurity Regional Workshops have been convened and/or supported by Australia since 2005, with scientific and technical support provided by DSTG.  The objectives of these workshops have been to assist BWC States Parties in the Asia-Pacific region to become more engaged in the work of the BWC in Geneva.  In doing so, the workshops reduce the possibility of bioterrorism in the region, and assists regional states to fulfil BWC obligations, including avoiding inadvertently assisting biological weapons programs being developed elsewhere.  This outreach process has also led to regional countries conducting their own specialised workshops on biosafety and biosecurity.  No workshops were conducted in 2021, however DSTG participated in the 2021 OPCW confidence-building exercise for the detection/analysis of ricin in complex samples.

(9) Включая вирусы и прионы.